Investigating the effects of a placebo cream on thermal pain responses in the brain

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This study uses functional magnetic resonance imaging (fMRI) to explore how the brain processes thermal pain across different body sites. Participants will receive both a placebo cream and a control cream while undergoing painful thermal stimulation. The research aims to understand the brain's somatotopic representation of pain and how these representations are affected by the presence of a placebo. By comparing brain activity before and during pain stimulation, the study seeks to reveal insights into pain perception and modulation.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Subject must be a volunteer with a minimum age of 18 years and must be able and willing to provide written informed consent.
* If female, the subject must be non-lactating, not pregnant, and using a reliable contraception method.
* Subject must be able to read and speak English.
* Subject must be able to understand and follow the instructions of the investigator and understand all screening questionnaires.
* Subject must have no current or recent history of pathological pain.
* Subject must have abstained from alcohol and substance use for 48 hours.
* Subject must pass all fMRI screening tests.

Exclusion Criteria:

* If female, pregnancy.
* Inability to tolerate the scanning procedures (e.g., claustrophobia).
* Metal in body or prior history working with metal fragments (e.g., as a machinist).
* Inability to tolerate heat pain applied to the forearm.
* Reporting temporary abnormal levels of pain.
* Allergic response to the exfoliating cream.
* Current presence of pain.
* Current or past history of psychoactive substance abuse or dependence.
* Dementias.
* Movement disorders except familial tremor.
* CNS infection.
* CNS vasculitis.
* Inflammatory disease or autoimmune disease.
* CNS demyelinating disease (e.g. multiple sclerosis).
* Space occupying lesions (mass lesions, tumors).
* Congenital CNS abnormality (e.g. cerebral palsy).
* Seizure disorder.
* History of closed head trauma with loss of consciousness.
* History of cerebrovascular disease (stroke, TIAs).
* Abnormal MRI (except changes accounted for by technical factors or UBOs.
* Neuroendocrine disorders (e.g., Cushings disease).
* Uncorrected hypothyroidism or hyperthyroidism.
* Current or past history of cancer.
* Recent history (within two years) of myocardial infarction, severe cardiovascular disease, or currently active cardiovascular disease (e.g. angina, cardiomyopathy).
* Uncontrolled hypertension or hypotension.
* Chronic pain syndromes.
* Chronic fatigue syndromes.
* A history of neurologic disease or neuropathic pain.
* Prior treatment within the last month with any of the following: antidepressants, mood stabilizers, glucocorticoids, opiates.
* Prior treatment with any of the following: antipsychotics, isoniazid, centrally active antihypertensive drugs (e.g. clonidine, reserpine).
* Any other contraindications for MRI examination (e.g., metallic implants such as pacemakers, surgical aneurysm clips, or known metal fragments embedded in the body).
* Current treatment for psychiatric disorders including mood, anxiety, substance abuse, attention-deficit/hyperactivity disorder (ADHD), psychosis.
* Neurological disorders (e.g., taking dopamine agonists for Parkinson's) Cardiovascular disease or medication (e.g., taking ACE (angiotensin-converting-enzyme) inhibitors for cardiac remodeling).
* Frequent smoking (\> 5 cigarettes / day).
* Frequent alcohol use (\> 14 drinks / week).
* Frequent migraines (\> 5 / month on average).

Where it's running

• Dartmouth College
  Hanover, New Hampshire, United States Recruiting

Study contacts

• Principal investigator: Tor D Wager, PhD — Dartmouth College
• Study coordinator: Tor D Wager, PhD
• Email: Tor.D.Wager@Dartmouth.edu
• Phone: 603-646-2196

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Cognitive Rehabilitation of Everyday Goals With GMT: How Different Ways of Delivery Work

  This study tests Goal Management Training to see if a Swedish version helps adults with acquired brain injury or chronic pain improve practical goal-directed thinking and daily functioning.

  Recruiting at 2 sites Karolinska Institutet · Luleå, Norrbotten County and 2 other locations · NCT07924774

• One-time Pain Reprocessing Therapy session for chronic pain at The Ottawa Hospital

  A single four-hour session of Pain Reprocessing Therapy is being tested to see if it can help adults with chronic pain feel better and have less pain.

  Recruiting Ottawa Hospital Research Institute · Ottawa, Ontario · NCT07919626

• Meaning-Based Psychotherapy for Adults with Chronic Pain

  This trial tests whether Meaning-Based Psychotherapy helps adults with chronic pain feel more purposeful, feel less depressed, and have a better quality of life compared with optimized usual care therapy.

  Recruiting Hospital Clinico Universitario San Cecilio · Granada, Granada · NCT07915440

• How chronic pain changes over time in kids with Duchenne Muscular Dystrophy

  This study is following children and teens with Duchenne Muscular Dystrophy for 6 months to see how their chronic pain changes and how it affects daily life.

  Recruiting Antalya Training and Research Hospital · Antalya, Antalya · NCT07892196

• CBD for Opioid Dependence and Pain on Buprenorphine

  This study tests whether different doses of cannabidiol (CBD) can affect pain and opioid cravings in adults with opioid use disorder who are on buprenorphine, using a short, randomized, placebo-controlled setup.

  Recruiting Early Phase 1 Yale University · West Haven, Connecticut · NCT07886606

• Cebranopadol for opioid withdrawal in adults with chronic pain

  This study tests whether cebranopadol can reduce withdrawal symptoms in adults with chronic pain who are physically dependent on prescribed opioids, compared with placebo.

  Recruiting at 2 sites Phase 2 Adneuris Therapeutics, Inc. · North Canton, Ohio and 1 other locations · NCT07874620

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.